Respiratory Syncytial Virus (RSV) Diagnostic News:

New All-in-One Test for COVID-19/Flu/RSV

On January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample. The TCA/GENETWORx Flu A-B/COVID Combo Test is a molecular diagnostic PCR test that detects two types of influenza viruses; influenza A and B and differentiates them from RSV, and SARS-CoV-2, the virus that causes COVID-19. The Flu A-B/COVID Combo Test provided by GENETWORx has a 98% accuracy rate for influenza, 99% for COVID-19, and 96% for RSV.”

Read the full article on RSV Diagnostic Market Report 2021: Growing Demand for Respiratory Syncytial Virus Diagnostic Industry Analysis by Trends, Growth, Top Company Profiles, CAGR Values and Opportunity | Covid-19 Impact Analysis.

Recent Mentions

Menu
Call Now 610-726-1205
By continuing to browse or by clicking "Accept Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Accept Cookies
By continuing to browse or by clicking "Accept Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Accept Cookies